Loading grant details…
Active
NON SBIR/STTR CONTRACTS
NIH (US)
NIAID- VRC HIV mAb-Research, Development, and Production to Support HIV Monoclonal Antibody Development
$131.45M
USD
| Funder | NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES |
|---|---|
| Recipient Organization | Leidos Biomedical Research, Inc. |
| Country | United States |
| Start Date | Feb 01, 2022 |
| End Date | Aug 14, 2027 |
| Duration | 2,020 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10722410 |
Grant Description
The NIAID mission and scope includes rapidly responding to infectious disease outbreaks through research, development, and testing of HIV vaccines and therapeutics
All Grantees
Leidos Biomedical Research, Inc.
Advertisement
Advertisement
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Start Year
2022
End Year
2027
Grantees
1
Related Grants
PHASE 1 AND PHASE 2 CLINICAL TRIALS FOR NEXT-GENERATION CORO...
NATIONAL INSTITUTE OF ALLERGY AND INFECT...
$2.78M USD
Frederick National Laboratory for Cancer Research (FNLCR) Ce...
NATIONAL CANCER INSTITUTE
$856.7K USD
Completion of ACTIV-2 Study
NATIONAL INSTITUTE OF ALLERGY AND INFECT...
$825.3K USD
Advertisement
